8av1 Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3 alpha (GSK-3 alpha ): Development and impact on temozolomide treatment of glioblastoma cells.
Resolution
2.15 Å
Binding residue (original residue number in PDB)
I62 F67 A83 K85 Y134 V135 P136 T138 L188 D200
Binding residue (residue number reindexed from 1)
I36 F41 A57 K59 Y104 V105 P106 T108 L158 D170
Annotation score
1
Enzymatic activity
Enzyme Commision number
2.7.11.1: non-specific serine/threonine protein kinase. 2.7.11.26: [tau protein] kinase.